Leonteq Securities’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Leonteq Securities's BEAM Position: Q3 2026 in Review
Leonteq Securities increased its Beam Therapeutics (BEAM) stake by 78% in Q3 2026, buying an estimated $603K and bringing the position to 49,594 shares worth $1.21M. The position accounts for 0.05% of the portfolio, ranked #215.
Leonteq Securities first reported a position in BEAM in Q4 2020 and has held it in 18 quarters since. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Leonteq Securities held 49,594 shares of Beam Therapeutics worth $1.21M as of Q3 2026.
- Leonteq Securities bought 21,668 Beam Therapeutics shares in Q3 2026, an estimated $603K.
- Beam Therapeutics made up 0.05% of Leonteq Securities's portfolio in Q3 2026, its #215 holding.
- Leonteq Securities first reported a position in Beam Therapeutics in Q4 2020 and has held it in 18 quarters since.
- 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.